Swiss National Bank Sells 25,900 Shares of DaVita Inc. (NYSE:DVA)

Swiss National Bank cut its stake in shares of DaVita Inc. (NYSE:DVA) by 16.6% in the fourth quarter, HoldingsChannel reports. The fund owned 130,300 shares of the company’s stock after selling 25,900 shares during the period. Swiss National Bank’s holdings in DaVita were worth $19,486,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Sequoia Financial Advisors LLC increased its stake in shares of DaVita by 6.2% in the fourth quarter. Sequoia Financial Advisors LLC now owns 1,897 shares of the company’s stock worth $284,000 after purchasing an additional 110 shares in the last quarter. SoundView Advisors Inc. purchased a new stake in DaVita in the 4th quarter worth $595,000. Moran Wealth Management LLC increased its stake in DaVita by 102.2% in the 4th quarter. Moran Wealth Management LLC now owns 110,322 shares of the company’s stock worth $16,499,000 after buying an additional 55,756 shares in the last quarter. Amundi lifted its position in shares of DaVita by 116.4% in the fourth quarter. Amundi now owns 446,386 shares of the company’s stock valued at $68,726,000 after acquiring an additional 240,126 shares in the last quarter. Finally, PNC Financial Services Group Inc. boosted its stake in shares of DaVita by 0.9% in the fourth quarter. PNC Financial Services Group Inc. now owns 12,854 shares of the company’s stock worth $1,922,000 after acquiring an additional 118 shares during the period. Institutional investors own 90.12% of the company’s stock.

DaVita Trading Up 0.0 %

DVA stock opened at $149.27 on Wednesday. The firm has a market cap of $11.94 billion, a PE ratio of 13.90, a price-to-earnings-growth ratio of 1.07 and a beta of 0.99. The firm has a fifty day moving average price of $158.80 and a 200 day moving average price of $157.61. The company has a debt-to-equity ratio of 23.18, a quick ratio of 1.21 and a current ratio of 1.26. DaVita Inc. has a fifty-two week low of $125.64 and a fifty-two week high of $179.60.

DaVita (NYSE:DVA) last posted its earnings results on Thursday, February 13th. The company reported $2.24 earnings per share for the quarter, topping analysts’ consensus estimates of $2.14 by $0.10. DaVita had a net margin of 7.31% and a return on equity of 115.48%. Sell-side analysts anticipate that DaVita Inc. will post 10.76 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

DVA has been the topic of several recent analyst reports. Cowen reissued a “hold” rating on shares of DaVita in a research note on Tuesday, February 18th. Sanford C. Bernstein set a $184.00 target price on shares of DaVita in a report on Friday, February 21st. Finally, Barclays raised their target price on shares of DaVita from $164.00 to $169.00 and gave the company an “equal weight” rating in a research note on Tuesday, February 18th. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating and two have given a buy rating to the company’s stock. According to MarketBeat.com, DaVita presently has a consensus rating of “Hold” and an average target price of $166.33.

DaVita Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.